Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.11.2021 | Case report

Sunitinib

Abnormal thyroid function and renal function, and drug resistance : case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Wu M, et al. Cytoreductive Nephrectomy Promoted Abscopal Effect of Camrelizumab Combined With Radiotherapy for Metastatic Renal Cell Carcinoma: A Case Report and Review of the Literature. Frontiers in Immunology 12: 15 Jun 2021. Available from: URL: http://doi.org/10.3389/fimmu.2021.646085 Wu M, et al. Cytoreductive Nephrectomy Promoted Abscopal Effect of Camrelizumab Combined With Radiotherapy for Metastatic Renal Cell Carcinoma: A Case Report and Review of the Literature. Frontiers in Immunology 12: 15 Jun 2021. Available from: URL: http://​doi.​org/​10.​3389/​fimmu.​2021.​646085
Metadaten
Titel
Sunitinib
Abnormal thyroid function and renal function, and drug resistance : case report
Publikationsdatum
01.11.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-05187-x

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Multiple drugs

Case report

Epoprostenol

Case report

Multiple drugs